JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation is allowed to use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website for educational purpose only. Bodily introduction of any kind into humans and animals is strictly forbidden by law. This product should only be handled by licenced qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused as a drug, food and cosmetic.
FREE Shipping for orders over $200
For this product you will need: BACTERIOSTATIC WATER For reconstitution.
Semaglutide is a glucagon-like peptide-1 (GLP-1) analogue that derives from the structural modifications of a synthetic peptide GLP-1 receptor agonist. There are various tissue models available that contain GLP-1 receptor systems which are investigated for intracellular signaling, peptide–receptor interactions and modulation of second-messenger pathways. As an artificial GLP-1 analog, semaglutide is used in controlled experimental conditions to study receptor binding dynamics, stability and downstream signaling.
First developed in 2012 by a Danish pharmaceutical company, Novo Nordisk, semaglutide has improved molecular stability and resistant to enzymatic degradation. These features make it a useful molecule to be explored in the field of peptide chemistry, receptor pharmacology and signalling networks. Semaglutide is sold strictly for scientific research and education only, and not for clinical use or human consumption.
From Pubchem
Synonyms: Semaglutide, Ozempic, RybelsusMolecular Formula: C187H291N45O59Molecular Weight: 4114 g/molCAS Number: 910463-68-2PubChem CID: 56843331
Semaglutide is of scientific interest because it interacts with glucagon-like peptide-1 (GLP-1) receptor systems, which form part of intricate regulatory networks that govern energy balance, nutrient sensing and peripheral signalling integration. Both processes are particularly well-suited to studies investigating the specificity of peptide–receptor interaction, signal duration and modulation, as semaglutide is a GLP-1 analogue with a structurally modified molecular backbone. [1].
Semaglutide’s influence on intracellular signaling networks governing metabolic circuitry, enteroendocrine communication, and neuroendocrine pathway integration has been systematically characterized. These analyses focus on mechanistic responses, pathway specificity and system-level effects as opposed to outcome-response endpoints [2]. Response pattern discrepancies along these lines have been compared under different experimental conditions to study the impact of GLP-1 analogue design on signalling kinetics.[3].
Cumulatively, semaglutide is a standard of compound for investigations of GLP-1–associated biochemical pathways, peptide stability and receptor-mediated signal transduction. Its characteristics facilitate continued experimentation within the laboratory concerning endocrine and metabolic signalling systems but do not suggest clinical effectiveness, therapeutic efficacy or application to human cases. [4]Â
Semaglutide has been reported to be studied in the context of GLP-1 receptor–mediated glucose-dependent signalling and endocrine control. As an enineered GLP-1 analogue, it has been used to investigate receptor engagement, intracellular messenger rolling and signal longevity in pancreatic and peripheral tissues. These characteristics facilitate the detailed examination of GLP-1–related signaling behavior in well-defined analytical settings.
Studies attibuted to semaglutide have centred around its engagement with metabolic signal networks, encompassing insulin-dependent communication pathways and glucose-sensing modalities as well as systemic endocrine mediation. Analysis of experimental comparison serves to put the emphasis on mechanistic variation in signal transduction and pathway activation rather than functional endpoints. Such studies may shed light on how GLP-1 analogues behave at molecular and cellular levels, but the findings do not suggest clinical utility or therapeutic relevance in humans [5].Â
Semaglutide is currently being assessed across advanced research programmes in neuroscience and cardiovascular systems, which also signifies enduring experimental interest in its receptor-mediated actions on various biological pathways. This work is focused on the dynamics of its molecular interactions, signal integration and system level behaviour in complex biology networks.
Additional exploratory work has centered on cardiovascular and metabolic signalling frameworks, with emphasis on mechanistic evaluation rather than outcome-based assessment. Semaglutide for sale available through our website is restricted to educational and research purposes and is supplied exclusively to qualified researchers. Only buy Semaglutide if you are a licensed researcher.
Semaglutide is a long-acting synthetic peptide analogue of glucagon-like peptide-1 (GLP-1), modified with a fatty acid side chain that promotes albumin binding and supports extended stability in serum-containing cell culture media. The structural modifications confer DPP-IV resistance and prolonged in vitro half-life, making the compound a useful tool for sustained-exposure receptor pharmacology studies.
In cell-based pharmacology research, Semaglutide engages the GLP-1 receptor (a class B G protein-coupled receptor) with high binding affinity in CHO-K1 and HEK293 cells expressing recombinant human GLP-1R. Functional assays measure Gas-coupled cAMP elevation, ß-arrestin recruitment, and downstream signalling through PKA, ERK, and CREB phosphorylation pathways in INS-1 and MIN6 beta-cell models.
Element CRP supplies this product at 5mg per vial. USA-manufactured via solid-phase peptide synthesis and verified at 99%+ purity by HPLC and Mass Spectrometry. Reconstitution with bacteriostatic water required. Store lyophilised at -20°C; stable for 24 months.
WARNING: For research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease. For use by qualified research professionals only.
Forgot password?
Country: United States (US-only registration)
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
Element CRP is a chemical supplier. Element CRP is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Element CRP is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
